{"id":1401,"date":"2024-05-10T15:16:35","date_gmt":"2024-05-10T13:16:35","guid":{"rendered":"https:\/\/www.incipit-pediatric.net\/trials\/novartis-asthma\/"},"modified":"2026-10-19T11:28:18","modified_gmt":"2026-10-19T09:28:18","slug":"novartis-asthma","status":"publish","type":"trials","link":"https:\/\/www.incipit-pediatric.net\/en\/trials\/novartis-asthma\/","title":{"rendered":"Novartis Asthma"},"content":{"rendered":"<p class=\"x_MsoNormal\"><strong>Double-blind, randomized, active-controlled, two-way cross-over study, with 12-week treatment duration per period, to evaluate the efficacy and safety of QMF149 (indacaterol acetate \/ mometasone furoate) compared to budesonide in children from 6 to less than 12 years of age with asthma?<\/strong><\/p>\n<p class=\"x_MsoNormal\">Double-blind, randomized, active-controlled, two-way cross-over study, with 12-week treatment duration per period, to evaluate the efficacy and safety of QMF149 (indacaterol acetate \/ mometasone furoate) compared to budesonide in children from 6 to less than 12 years of age with asthma<\/p>\n<p class=\"x_MsoNormal\">The purpose of this study is to evaluate the efficacy and safety of QMF149 (indacaterol acetate\/mometasone furoate) compared to budesonide in children aged 6 to less than 12 years with mild to moderate asthma.<\/p>\n<p class=\"x_MsoNormal\">The primary objective of this study is to demonstrate the superiority of indacaterol (acetate)\/mometasone (furoate) (QMF149) over budesonide in terms of FEV1 at week 12 of each treatment period.<\/p>\n<p class=\"x_MsoNormal\">Approximately 200 pediatric patients will be randomized to obtain 182 complete pediatric asthma patients.<\/p>\n<div><strong>Status: Completed<\/strong>.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Double-blind, randomized, active-controlled, two-way cross-over study, with 12-week treatment duration per period, to evaluate the efficacy and safety of QMF149 (indacaterol acetate \/ mometasone furoate) compared to budesonide in children from 6 to less than 12 years of age with asthma? Double-blind, randomized, active-controlled, two-way cross-over study, with 12-week treatment duration per period, to evaluate [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-1401","trials","type-trials","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.incipit-pediatric.net\/en\/wp-json\/wp\/v2\/trials\/1401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.incipit-pediatric.net\/en\/wp-json\/wp\/v2\/trials"}],"about":[{"href":"https:\/\/www.incipit-pediatric.net\/en\/wp-json\/wp\/v2\/types\/trials"}],"wp:attachment":[{"href":"https:\/\/www.incipit-pediatric.net\/en\/wp-json\/wp\/v2\/media?parent=1401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}